INDUCTION OF TRANSPLANTATION TOLERANCE TO RAT CARDIAC ALLOGRAFTS BY INTRATHYMIC INOCULATION OF ALLOGENEIC SOLUBLE PEPTIDES

Citation
Sf. Oluwole et al., INDUCTION OF TRANSPLANTATION TOLERANCE TO RAT CARDIAC ALLOGRAFTS BY INTRATHYMIC INOCULATION OF ALLOGENEIC SOLUBLE PEPTIDES, Transplantation, 56(6), 1993, pp. 1523-1527
Citations number
33
Categorie Soggetti
Immunology,Surgery
Journal title
ISSN journal
00411337
Volume
56
Issue
6
Year of publication
1993
Pages
1523 - 1527
Database
ISI
SICI code
0041-1337(1993)56:6<1523:IOTTTR>2.0.ZU;2-7
Abstract
Since intrathymic (i.t.) injection of UV-B-irradiated spleen cells (SC ) or purified resting allogeneic T cells, but not resting B cells, den dritic cells, or macrophages induces specific tolerance in transiently immunosuppressed recipients, we hypothesized that presentation of don or MHC peptide Ag by the host thymic APCs may convey a tolerogenic sig nal to the recipient. This study examined if i.t. inoculation of allog eneic soluble Ag obtained from 3 M KCl extracts of purified resting T cells can induce specific tolerance to cardiac allografts in transient ly immunomodulated recipients. We have now shown that i.t. inoculation of donor soluble Ag on day -7 combined with 1 ml ALS on days -7 and 0 leads to indefinite WF cardiac allograft survival (>200 days) in Lewi s recipients. This finding was reproducible in sublethally irradiated (200 rads TBI) ACI recipients of i.t. Lewis soluble Ag. In contrast, A CI cardiac allografts were promptly rejected in ALS-treated Lewis reci pients of i.t. WF soluble Ag, confirming the donor specificity of such immunologic manipulation. Extrathymic inoculation of WF soluble Ag vi a the intravenous route in controls failed to prevent normal graft rej ection in ALS-treated recipients. The long-term unresponsive recipient s specifically and permanently accepted donor-type, second-set cardiac allografts. The observation that thymectomy performed 7 days after i. t. Ag injection led to graft rejection strongly suggests that the earl y phase of induction of donor-specific tolerance is dependent on the p resence of donor alloantigens in the host thymus. This approach may ha ve important clinical therapeutic potential in the induction of transp lantation tolerance.